Lip augmentation is not just for women who want larger, sexier lips. As people age, their lips lose fullness which makes them appear older. While injectable fillers can combat aging around the lips and mouth, not all are created equal – some can even lead to long-lasting complications, say presenters at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2006 conference in San Francisco.
What if you couldn’t perform daily activities, such as exercising or running with your children, because of overly large breasts that caused unending pain? Despite existing scientific studies that outline the medical necessity for breast reduction, many insurance companies are denying thousands of women the procedure each year because of rigid, unfounded conditions to secure coverage, according to a study presented at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2006 conference in San Francisco.
Blackwell Publishing is set to break into an exciting new area of clinical psychiatry with its new journal – Early Intervention in Psychiatry. The journal will be launched at the IEPA Conference in Birmingham in October 2006, and will publish its inaugural issue in February 2007.
Snorers Cause Bed Partners to have EEG Arousals (91)Sean Tolhurst, University of Queensland and SNORE Australia – A new study has found that people with sleep apnea cause their bed-partners to have EEG arousals and sleep disturbance. Up until now there has been limited scientific information into how much a patient with Obstructive Sleep Apnea disturbs a sleeping bed partner. This study investigated the impact that snoring and sleep apnea events have on the bed-partner.
Lung cancer patients treated with an experimental new drug lived over a third longer than patients treated with standard chemotherapy, according to data released. The phase II study, carried out by UK biotech company Antisoma plc, looked at 70 patients with non-small cell lung cancer (NSCLC), the most common type of lung cancer.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. today announced that ceftobiprole, a novel cephalosporin(1) antibiotic in Phase III clinical trials, was found to be active against complicated skin infections caused by common, potentially deadly bacteria, including MRSA. These data were from two poster presentations given at the 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). These data also were highlighted by ICAAC. Ceftobiprole is being co-developed with Basilea Pharmaceutica, Ltd. through an exclusive worldwide collaboration.
Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that the results of a Phase 1 clinical trial of HGS004 (CCR5 mAb) demonstrate that it was well tolerated and exhibited antiviral activity in patients who are infected with HIV-1, the retrovirus that causes acquired immunodeficiency syndrome (AIDS). The results were reported in San Francisco in an oral presentation at the American Society for Microbiology’s 46th Annual Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
Only one in five people with HIV in poor and middle-income countries receives the drugs that treat the virus, said a report by the U.S. Centers for Disease Control and Prevention on Thursday.
There may be finally some relief for people suffering from debilitating migraine attacks, as now a hand held “zapper gun” could bring relief to millions, according to experts.
Researchers around the globe are looking for connections between osteoporosis, a bone-wasting disease that affects some 25 percent of the world’s over-50s, and a host of other ailments from diabetes to Parkinson’s disease.